title: Interleukin interrupted: a new strategy for the treatment of pancreatic cancer.
authors.affiliation: Memorial Sloan Kettering Cancer Center leachs@mskcc.org.
authors.forename: Steven D
authors.initials: SD
authors.lastname: Leach
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D018925:Chemokines / Q000378:metabolism*; D005260:Female; D006801:Humans; D020381:Interleukin-17 / Q000276:immunology* / Q000378:metabolism*; D008297:Male; D010190:Pancreatic Neoplasms / Q000378:metabolism* / Q000473:pathology*; D053722:Receptors, Interleukin-17 / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D018925:Chemokines; D020381:Interleukin-17; D053722:Receptors, Interleukin-17